Sort
78,016 grants matching “breast cancer”
Integration of ER-related signaling in breast cancer
$1,417,547Robert R. Clarke · Georgetown University · U54 · FY2012 · CA
OSUCCC CUSP2CT
$1,417,500Electra D. Paskett · Ohio State University · U01 · FY2025 · CA
Integrated analyses of genetics, epigenetics, and gene expression
$1,417,383Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2024 · CA
Impact of Stretching on Tumor growth and Metastasis
$1,417,327Lisbeth Berrueta Carrillo · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE
Assessment of serum peptide profiling to detect cancer-specific patterns
$1,417,183Paul Tempst · Sloan-Kettering Inst Can Research · U24 · FY2009 · CA
Bay Area Breast Cancer &the Environment Research Center
$1,417,086University Of California San Francisco · U01 · FY2004 · ES
Mechanisms of non-classical multidrug resistance in cancer
$1,416,959Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Determining and targeting mechanisms controlling cancer cell division
$1,416,505Jan M Skotheim · Stanford University · P01 · FY2025 · CA
Discovery Expansion and Replication
$1,415,741Douglas Frederick Easton · Harvard School Of Public Health · U19 · FY2012 · CA
Botanical Estrogens: Mechanisms, Dose and Target Tissues
$1,415,653William G. Helferich · University Of Illinois At Urbana-Champaign · P50 · FY2014 · AT
Center for Health Research with Tribes in SD-MT-WY
$1,415,563M Benjamin Perryman · University Of South Dakota · P20 · FY2007 · MD
ALTERNATIVE BREAST CANCER IMAGING MODALITIES
$1,414,991Dartmouth College · P01 · FY2001 · CA
Communication-based Strategies to Eliminate Cancer Disparities
$1,414,713Matthew W. Kreuter · Washington University · P50 · FY2012 · CA
MicroPET/SPECT/CT animal imaging device for translational research
$1,414,616Eugene Fine · Albert Einstein College Of Medicine · S10 · FY2010 · RR
Cellular Interactions with Thrombospondin
$1,414,291David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities
$1,414,272Lois B. Travis · University Of Rochester · R01 · FY2013 · CA
Adapting MultiPLe behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health
$1,414,142Wendy Demark-Wahnefried · University Of Alabama At Birmingham · P01 · FY2021 · CA
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
$1,413,657Matthew J Ellis · Baylor College Of Medicine · U01 · FY2018 · CA
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHI
$1,413,286Stanford University · N01 · FY2000 · WH
THE APPALACHIA CANCER NETWORK
$1,413,201University Of Kentucky · U01 · FY2000 · CA
A PARTNERSHIP TRAINING PROGRAM: STUDYING TARGETED DRUG DELIVERY USING NANOPARTICLES IN BREAST CANCER DIAGNOSIS AND THERAPY
$1,412,749Howard University · · FY2010 · Department of Defense
Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
$1,412,352Aaron Thomas Gerds · Case Western Reserve University · UG1 · FY2025 · CA
Center of Excellence in Eliminating Disparities
$1,412,350Elizabeth Ann Calhoun · University Of Illinois At Chicago · P60 · FY2012 · MD
DEVELOPMENT OF A NOVEL TUMOR-TARGETING AND TUMOR-PENETRATING NANOSYSTEM FOR BREAST CANCER THERAPY
$1,412,302Endurx Pharmaceuticals Inc · · FY2020 · Defense Health Agency
Botanical Estrogens: Mechanisms, Dose and Target Tissues
$1,411,870William G. Helferich · University Of Illinois At Urbana-Champaign · P50 · FY2013 · AT